1-26-24: Clinical Trial Announcement
1-26-24 Clinical Trial Announcement: Multiple Sites Now Open In and Outside the U.S. To learn about additional sites that have opened: Information on ION717 Clinical Trial 10-4-23 Community Statement from Ionis Pharmaceuticals 12-21-23 Clinical Trial Announcement from Ionis Pharmaceuticals
Gerold Schmitt-Ulms, PhD
Grant Title:
Bridging the pre-clinical gap for a small brain-penetrant molecule that reduces PrPC levels
Location:
Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto
Grant Year: 2024
Debbie McKenzie, PhD
Grant Title:
Modulation of Toll-Like Receptor Signaling: Unveiling Neuroinflammation and Therapeutic Strategies in Creutzfeldt-Jakob Disease
Location:
University of Alberta
Grant Year: 2024
Dr. Surabhi Mehra
Grant Title:
Understanding the molecular mechanism of spontaneous prion emergence in knock-in mouse models
Location:
Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto
Grant Year: 2024
Arielle Hay, Ph.D.
Grant Title:
Generating cerebral organoids from donors with sporadic Creutzfeldt-Jakob Disease
Location:
Postdoctoral Research Fellow at Rocky Mountain Laboratories, National Institutes of Health, Hamilton, Montana
Grant Year: 2024
JoaquÃn Castilla, PhD
Grant Title:
Exploring the efficacy of dominant negative protein-based gene therapy for different prion diseases: in vivo proof-of-concept study
Location:
Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain
Grant Year: 2024
Dr. Adriano Aguzzi and Davide Caredio
Grant Title:
Investigation of Glycoprotein Nonmetastatic Melanoma protein B (GPNMB) as potential therapeutic target in Prion Diseases
Location:
University of Zurich
Grant Year: 2024
Bruce W. Lawson
March 29, 1956 – December 9, 2023
Jane Sanderson
March 11, 1950 – January 10, 2007
Natalie Myers
December 16, 1998 – August 23, 2023
